Robert Fox, M.D., Ph.D.
Rheumatology Clinic
Scripps Memorial Hospital / Ximed

Dr. Rober FoxDr. Robert I. Fox received his undergraduate degree (BS, Biophysics summa cum lauda) from the Honors College of the University of Michigan. He then completed the combined M.D.-Ph.D. (Medical Scientist Training Program) at Harvard Medical School and Albert Einstein College of Medicine in New York with Ph.D. (Molecular Biology) in 1972 and his M.D. in 1974. He then completed his internship and residency in Internal Medicine at Stanford University, followed by his Rheumatology fellowship also at Stanford University in 1980. He joined the faculty of Scripps Medical and Research Foundation in 1980. He was at the Scripps Clinic location from 1980 until 1999, when he moved to the Scripps-Ximed Medical group, which is located on the main campus of Scripps Memorial Hospital and University of California San Diego (UCSD) (1999-present). Dr. Fox specializes in the pathogenesis and treatment of Sjögren’s syndrome, Dr Fox has edited a number of journals and pursued research interests through his role as principal investigator in multicenter clinical trials and his own NIH funded research programmes. Additionally, Dr Fox serves as a member of a number of advisory boards such as the ACR Advisory Board for Sjogren’s Syndrome and the Advisory Board for the National Sjögren’s Syndrome Foundation. In recent years, he has served as Rheumatology Editor for Medscape and written over an additional 100 articles and editorials for practicing physicians and patients that can be found by web search using “Medscape or “WebMD” and “Robert Fox.” Dr. Fox has been involved in studies of cevimeline for Sjögren’s syndrome for over 15 years, since the drug was originally recognized as a secretagogue in collaborative studies with the drug’s original founder (Prof. A. Fisher) and the neurochemistry group at Salk Institute. He wrote the clinical protocols for the pivotal trials leading to FDA approval of the drug and has served as a consult in the past to Signal Pharma (originator of the drug for use in neuroprotection), Snow Brand Pharma (original use as a secretagogue) and currently to Daiichi Pharma.

Click here to view Dr. Fox's Curriculum vitae.



9850 Genesee Avenue, Suite 910
La Jolla, CA 92037
Phone: (858) 457-2023
FAX: (858) 457-2721

Return to Home page Contact Dr. Robert Fox, M.D.